SEC Form 4 · accession 0001192482-15-000020

Spark Therapeutics, Inc. · ONCE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

10% Owner

Period of report

Feb 4, 2015

Accepted (ET)

Feb 5, 2015 · 4:58 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001609351

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Feb 4, 2015	C	1,000,000	—	A	5,943,629	D
Common Stock^F2	Feb 4, 2015	C	2,795,031	—	A	8,738,660	D
Common Stock^F3	Feb 4, 2015	C	61,552	—	A	8,800,212	D
Common Stock	Feb 4, 2015	P	100,000	$23.00	A	8,900,212	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Series A Preferred Stock^F1	—	Feb 4, 2015	C	1,000,000	D	—	—	Common Stock	1,000,000	D
Series B Preferred Stock^F2	—	Feb 4, 2015	C	2,795,031	D	—	—	Common Stock	2,795,031	D
Accrued Preferred Stock Dividends^F3	—	Feb 4, 2015	C	61,552	D	—	—	Common Stock	61,552	D

F1Shares of Series A Preferred Stock automatically converted into shares of the Common Stock on a one-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering on February 4, 2015.
F2Shares of Series B Preferred Stock automatically converted into shares of the Common Stock on a one-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering on February 4, 2015.
F3Paid-in-kind dividends declared and paid on the Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock on a one-for-one basis without payment of further consideration upon the closing of the issuer's initial public offering on February 4, 2015.